Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Medicina (Kaunas) ; 58(10)2022 Sep 27.
Artigo em Inglês | MEDLINE | ID: mdl-36295518

RESUMO

Ever since it was first described in 1760, acute type A aortic dissection has created difficulties in its management. The recent COVID-19 pandemic revealed that extrapulmonary manifestations of this condition may occur, and recent reports suggested that aortic dissection may be amongst them since it shares a common physiopathology, that is, hyper-inflammatory syndrome. Cardiac surgery with cardiopulmonary bypass in the setting of COVID-19-positive patients carries a high risk of postoperative respiratory failure. While the vast majority accept that management of type A aortic dissection requires urgent surgery and central aortic therapy, there are some reports that advocate for delaying surgery. In this situation, the risk of aortic rupture must be balanced with the possible benefits of delaying urgent surgery. We present a case of acute type A dissection with COVID-19-associated bronchopneumonia successfully managed after delaying surgery for 6 days.


Assuntos
Dissecção Aórtica , Ruptura Aórtica , Broncopneumonia , COVID-19 , Humanos , COVID-19/complicações , Broncopneumonia/complicações , Pandemias , Dissecção Aórtica/complicações , Dissecção Aórtica/cirurgia , Ruptura Aórtica/complicações , Doença Aguda , Resultado do Tratamento
2.
Interact Cardiovasc Thorac Surg ; 9(1): 89-93, 2009 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-19372098

RESUMO

In this study, we tried to compare the efficacy and safety of betaxolol vs. metoprolol immediately postoperatively in coronary artery bypass grafting (CABG) patients and to determine whether prophylaxy for atrial fibrillation (AF) with betaxolol could reduce hospitalization and economic costs after cardiac surgery. Our trial was open-label, randomized, multicentric enrolling 1352 coronary surgery patients randomized to receive betaxolol or metoprolol. The primary endpoints were the composites of 30-day mortality, in-hospital AF (safety endpoints), duration of hospitalization and immobilization, quality of life, and the above endpoint plus in-hospital embolic event, bradycardia, gastrointestinal symptoms, sleep disturbances, cold extremities (efficacy plus safety endpoint). At the end of the study the incidence and probability of early postoperative AF with betaxolol was lower than with metoprolol in coronary surgery (P<0.0001). In the two study groups minor side effects were similar and no major complication was reported (P<0.001). Patient compliance was good and the general condition improved due to shortened hospitalization and immobilization with subsequent improvement in the psychological status, less arrhythmias and lack of significant side effects. In conclusion, because of its efficacy and safety, betaxolol was superior to metoprolol for the prevention of the early postoperative AF in coronary surgery.


Assuntos
Antagonistas Adrenérgicos beta/uso terapêutico , Fibrilação Atrial/prevenção & controle , Betaxolol/uso terapêutico , Ponte de Artéria Coronária/efeitos adversos , Metoprolol/uso terapêutico , Antagonistas Adrenérgicos beta/efeitos adversos , Antagonistas Adrenérgicos beta/economia , Idoso , Fibrilação Atrial/economia , Fibrilação Atrial/etiologia , Fibrilação Atrial/mortalidade , Betaxolol/efeitos adversos , Betaxolol/economia , Ponte Cardiopulmonar , Ponte de Artéria Coronária/economia , Ponte de Artéria Coronária/mortalidade , Análise Custo-Benefício , Custos de Medicamentos , Feminino , Custos Hospitalares , Mortalidade Hospitalar , Humanos , Imobilização , Tempo de Internação , Masculino , Metoprolol/efeitos adversos , Metoprolol/economia , Pessoa de Meia-Idade , Cooperação do Paciente , Assistência Perioperatória , Qualidade de Vida , Romênia , Fatores de Tempo , Resultado do Tratamento
3.
Kardiol Pol ; 60(6): 535-40, 2004 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-15334153

RESUMO

BACKGROUND: Systemic embolisation occurs in 22% to 50% of patients with infective endocarditis (IE). Up to 65% of embolic events (EE) involve the central nervous system which increases the mortality rate. Several echocardiographic studies have demonstrated higher embolic rates with the increase of vegetation (VEG) dimensions and mobility. AIM: To define echocardiographic parameters which can help in identifying patients with a high risk of EE and to assess the value of transesophageal echocardiography (TEE) in predicting EE in patients with IE. METHODS: 236 patients (58% male, mean age 47.8+/-6) diagnosed with IE according to Duke criteria were followed for 3 years or until cardiac surgery. Echocardiographic parameters measured on VEG included the maximum length, thickness, the narrowest diameter, neck and mobility. RESULTS: The rate of EE was 51.27% without any significant differences with respect to gender, age, fever, anaemia, VEG site or the presence of a significant regurgitation murmur. The univariate analysis showed a significant correlation between EE and IE caused by staphylococcus, IE of the right heart, and the length as well as mobility of VEG. The only independent predictors of EE were the maximum VEG length >15 mm and the increased mobility of VEG with a maximal displacement angle >60.7 degrees. In 23% of patients EE occurred after the initiation of antibiotic treatment. VEG in this group were big and very mobile (length >15 mm, maximal angle of displacement >65 degrees). CONCLUSIONS: 1. Vegetation dimension and mobility determined by TEE are important predictors of the embolic risk. 2. Significant echocardiographic predictors of embolic events included vegetation length >15 mm, neck/thickness ratio >0.69, and maximal angle of displacement of vegetation during cardiac cycle >60.7 degrees. 3. During antibiotic treatment, the embolic risk depends only on vegetation mobility and dimension.


Assuntos
Ecocardiografia Transesofagiana , Embolia/etiologia , Endocardite Bacteriana/diagnóstico por imagem , Adulto , Valva Aórtica/diagnóstico por imagem , Embolia/diagnóstico por imagem , Endocardite Bacteriana/complicações , Endocardite Bacteriana/terapia , Feminino , Seguimentos , Humanos , Masculino , Pessoa de Meia-Idade , Valva Mitral/diagnóstico por imagem , Valor Preditivo dos Testes , Fatores de Risco , Infecções Estafilocócicas/complicações , Infecções Estafilocócicas/diagnóstico por imagem
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA